These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28923765)

  • 1. Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis.
    Thi THH; Priemel PA; Karrout Y; Driss V; Delbeke M; Dendooven A; Flament MP; Capron M; Siepmann J
    Int J Pharm; 2017 Nov; 533(1):26-33. PubMed ID: 28923765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.
    Driss V; El Nady M; Delbeke M; Rousseaux C; Dubuquoy C; Sarazin A; Gatault S; Dendooven A; Riveau G; Colombel JF; Desreumaux P; Dubuquoy L; Capron M
    Mucosal Immunol; 2016 Mar; 9(2):322-35. PubMed ID: 26174763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses.
    Sarazin A; Dendooven A; Delbeke M; Gatault S; Pagny A; Standaert A; Rousseaux C; Desreumaux P; Dubuquoy L; Capron M
    PLoS One; 2018; 13(12):e0209681. PubMed ID: 30592734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights.
    Foligné B; Plé C; Titécat M; Dendooven A; Pagny A; Daniel C; Singer E; Pottier M; Bertin B; Neut C; Deplanque D; Dubuquoy L; Desreumaux P; Capron M; Standaert A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31212833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.
    Gasmi H; Danede F; Siepmann J; Siepmann F
    J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
    Jiang T; Singh B; Li HS; Kim YK; Kang SK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2014 Feb; 35(7):2365-73. PubMed ID: 24342722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].
    Zhou XL; He JT; Zhou ZT; Ma SF; Jiang Y; Wang Y
    Yao Xue Xue Bao; 2010 Aug; 45(8):1057-63. PubMed ID: 21351596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of PLGA microspheres loaded with divalent DNA vaccine encoding the ompA gene of Aeromonas veronii and the hly gene of Aeromonas hydrophila in mice.
    Gao S; Zhao N; Amer S; Qian M; Lv M; Zhao Y; Su X; Cao J; He H; Zhao B
    Vaccine; 2013 Nov; 31(48):5754-9. PubMed ID: 24012571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of cephalexin loaded PLGA microspheres.
    Chaisri W; Hennink WE; Okonogi S
    Curr Drug Deliv; 2009 Jan; 6(1):69-75. PubMed ID: 19418958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment.
    Gaddipati S; Lu Q; Kasetti RB; Miller MC; Lu Q; Trent JO; Kaplan HJ; Li Q
    PLoS One; 2015; 10(3):e0121185. PubMed ID: 25803615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.